Federal Register / Vol. 66, No. 121 / Friday, June 22, 2001 / Notices 33549

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: July 10, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

Washington, DC 20037.

Contact Person: Martha Ann Carey,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6151, MSC 9608,

Bethesda, MD 20892–9606, 301–443–1606.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: July 12, 2001.

Time: 12 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: St. Gregory Hotel, 2033 M Street,

NW., Washington, DC 20036–3305.

Contact Person: Joel Sherrill, Scientific

Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6149, MSC 9606,

Bethesda, MD 20892–9606, 301–443–6102.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: July 13, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: St. Gregory Hotel, 2033 M Street,

NW., Washington, DC 20036–3305.

Contact Person: Joel Sherrill, Scientific

Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6149, MSC 9606,

Bethesda, MD 20892–9608, 301–443–6102.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: July 19–20, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Governor’s House, 1615 Rhode

Island Avenue, NW., Washington, DC 20036.

Contact Person: Irina Gordienko, Scientific

Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6154H, MSC

9608, Bethesda, MD 20892–9608, 301–443–

4869.

(Catalogue of Federal domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Service

Awards for Research Training, National

Institutes of Health, HHS)

Dated: June 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–15764 Filed 6–21–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Training and Career Development.

Date: July 11, 2001.

Time: 4 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Ritz Carlton, Pentagon City,

1250 S. Hayes Street, Arlington, VA 22202.

Contact Person: Khursheed Asghar, Chief,

Basic Sciences Review Branch, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, Msc

957, Bethesda, MD 20892–9547, (301) 443–

2620.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Reseach Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: June 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–15766 Filed 6–21–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Research Dissemination Project’’.

Date: June 26, 2001.

Time: 9:30 a.m. to 12 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Lyle Furr, Contract Review

Specialist, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 435–1439.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Pharmacokinetic Analysis Resource

Center’’.

Date: June 27, 2001.

Time: 10 a.m. to 11:30 a.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1439.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training: 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: June 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–15767 Filed 6–21–01; 8:45 am]

BILLING CODE 4140–01–M